-
Mashup Score: 1
PURPOSE Minimal residual disease (MRD) can predict outcomes in patients with multiple myeloma, but limited data are available on the prognostic impact of MRD when assessed at serial time points in the context of maintenance therapy after autologous stem-cell transplant (ASCT) and the interaction between MRD and molecular risk. METHODS Data from a large phase III trial (Myeloma XI) were examined…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
PURPOSE Minimal residual disease (MRD) can predict outcomes in patients with multiple myeloma, but limited data are available on the prognostic impact of MRD when assessed at serial time points in the context of maintenance therapy after autologous stem-cell transplant (ASCT) and the interaction between MRD and molecular risk. METHODS Data from a large phase III trial (Myeloma XI) were examined…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3Graham's page - 3 year(s) ago
Help Graham Jackson raise money to support Myeloma UK
Source: JustGivingCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
TO THE EDITOR:
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0AL amyloidosis: learn from the experts - 3 year(s) ago
This medical education meeting is organised and fully funded by Janssen-Cilag Ltd and is restricted to UK based healthcare professionals only. Janssen are pleased to invite you to ‘AL amyloidosis: learn from the experts’, an afternoon of medical education which will take place virtually on Tuesday 23rd November 2021 at 13:00-17:00. Our co-chairs, Professor Graham Jackson, Professor Guy…
Source: BigMarker.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
Gain of 1q22 at diagnosis portends poorer outcomes in multiple myeloma (MM), but the prognostic significance of acquired 1q22 gain is unknown. We identified 63 MM patients seen at Mayo Clinic from 1/2004 to 12/2019 without 1q22 gain at diagnosis who acquired it during follow up and compared them to …
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2
‘The sooner we all act, the sooner we can get this transmission rate down, and the greater the prospect of having a Christmas with our families’
Source: road.ccCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Lymphoma Action | Lymphoma Management Course - 3 year(s) ago
Our popular Lymphoma Management Course returns virtually for a second year, with an additional fifth interactive session. View the programme Book your place through GoToWebinar (£55)
Source: Lymphoma ActionCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2'I'm running with the person who saved my life' - 3 year(s) ago
A student says it will be “so special” to do the London Marathon alongside her bone marrow donor.
Source: BBC NewsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Main Entrance - 3 year(s) ago
4th Annual Meeting of the International Academy for Clinical Hematology (IACH) September 24-26, 2021
Source: 4th Annual IACH MeetingCategories: Hem/Oncs, Latest HeadlinesTweet
Huge thanks to @_DrCP Ruth de Tutte Roger Owen @kennycairns @cruk @leeedsctru @DrGarethMorgan1 Faith Davies @profBigG and the entire brilliant myeloma XI team https://t.co/zAPiyLOYUE